Endra Life Sciences announced its board of directors has appointed Alexander Tokman as acting CEO to replace Francois Michelon, who stepped down from his role as CEO and as a member of the board of directors to pursue other endeavors. The company also announced the addition to its senior management team of Ziad Rouag as head of regulatory and clinical affairs and Richard Jacroux as CFO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDRA: